Oct 11, 2018 - The stock recovered from a surprising rejection at the end of August, but has tumbled once again in the first half of October.
Aug 27, 2018 - See which stocks are posting big moves after the bell.
Aug 11, 2018 - Biogen's stock got a boost from two material events last month.
Jul 25, 2018 - Looking for the next Spinraza.
Jul 24, 2018 - Biogen (BIIB) beats estimates on both counts in the second quarter. The company's multiple sclerosis drugs' sales up sequentially amid competition.
Jul 18, 2018 - It has been a pretty ho-hum week for the biotech sector with a few regulatory updates. Amgen resubmits BLA for osteoporosis drug and Advaxis surges on positive news from FDA.
Jul 15, 2018 - Biogen and Amgen have been two of the best performing biotechs for a decade. But one stock clearly has an easier path toward value creation.
Jul 12, 2018 - One successful drug on the market. Two potential approvals on the way. Six big partners. But do the numbers add up to buying Ionis right now?
Jul 12, 2018 - Bristol-Myers' (BMY) Opdivo in combination with its Yervoy received the FDA approval to treat patients with metastatic colorectal cancer (mCRC) that has progressed following treatment with fluoropyrimidine, oxaliplatin and irinotecan.
Jul 11, 2018 - Summit Therapeutics (SMMT) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.